Avoro Capital Advisors LLC boosted its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 690.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,555,555 shares of the biotechnology company’s stock after buying an additional 6,600,000 shares during the […]